MedPath

Bariatric Surgery vs. Lifestyle Modification for NASH

Not Applicable
Conditions
NASH - Nonalcoholic Steatohepatitis
Registration Number
NCT04298736
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

Randomized Controlled Trial comparing the effects of Bariatric Surgery vs. Lifestyle modification on NASH resolution.

Detailed Description

Patients with biopsy-proven NASH will be randomized to either bariatric surgery or lifestyle interventions. After 1-year follow-up a liver biopsy will be done to evaluate NASH resolution

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • BMI between 30 and 45
  • with biopsy-proven NASH
  • with or without type 2 diabetes
  • that fit for bariatric surgery.
Exclusion Criteria
  • borderline NASH ou cirrhosis;
  • alcohol consumption (> 20 g/day for men and > 10 g/day for women, for the last 2 years);
  • other hepatic diseases (such as viral hepatitis, autoimmune hepatitis, drug-induced hepatic disease, Wilson's disease, hemochromatosis);
  • HIV infection;
  • unable to provide informed consent;
  • previous foregut or bariatric surgery;
  • malignancy;
  • patients that unfit for bariatric surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
NASH resolution12 months

NASH resolution evaluated by liver biopsy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital de Clínicas de Porto Alegre

🇧🇷

Porto Alegre, RS, Brazil

Hospital de Clínicas de Porto Alegre
🇧🇷Porto Alegre, RS, Brazil
Guilherme S Mazzini, MD, PhD
Contact
+55(51)981364873
guimazzini@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.